説明
Xinep 5 ml Eye Drops (Nepafenac Ophthalmic Suspension 0.1% w/v) is a specialized non-steroidal anti-inflammatory drug (NSAID) manufactured by Sunways (India) Pvt Ltd. engineered specifically for the management of pain and inflammation associated with cataract surgery. As a prodrug with unique lipophilic properties, Xinep offers superior ocular tissue penetration, making it an essential component of modern perioperative ophthalmic protocols.
1. Manufacturer Profile: Sunways (India) Pvt Ltd
Sunways India is a premier pharmaceutical organization specializing in ophthalmic and ENT care, known for its focus on advanced delivery mechanisms and patient-centric research.
- Manufacturing Standards: Produced in WHO-GMP certified facilities, ensuring that each 5 ml suspension maintains precise particle distribution for consistent dosing.
- Innovation: Sunways utilizes high-purity Nepafenac to ensure that Xinep matches the clinical efficacy of innovator brands while remaining accessible to a global patient base.
2. Composition & Ingredients
Each 1 ml of Xinep Eye Drops contains:
- Active Ingredient: Nepafenac 1 mg (0.1% w/v).
- Preservative: Benzalkonium Chloride 0.005% w/v.
- Vehicle: Sterile aqueous suspension with specialized stabilizers for enhanced corneal contact time.
3. Mechanism of Action: How It Works
Xinep operates as a targeted anti-inflammatory agent through a unique “prodrug” activation process.
A. Targeted Prodrug Activation
Upon instillation, Nepafenac penetrates the cornea. Intraocular hydrolases then convert the prodrug into its active form, Amfenac. This localized conversion ensures that the highest concentration of the active drug is delivered directly to the iris, ciliary body, and retina, minimizing systemic side effects.
B. COX-1 and COX-2 Inhibition
Amfenac is a potent inhibitor of the cyclooxygenase (COX-1 and COX-2) enzymes. By blocking these enzymes, Xinep halts the synthesis of prostaglandins—the primary chemical mediators of pain, swelling, and inflammation in the eye. This prevents post-operative complications like cystoid macular edema (CME).
4. Therapeutic Indications
Xinep 5 ml is clinically indicated for:
- Post-Operative Inflammation: Reducing redness and swelling following cataract extraction.
- Cataract Surgery Pain: Preventing and treating ocular pain during the recovery period.
- Cystoid Macular Edema (CME): Often prescribed as a preventative measure in high-risk diabetic patients undergoing eye surgery.
5. Clinical Comparison: Xinep vs. Patanol
| Feature | Xinep (Nepafenac) | Patanol (Olopatadine) |
|---|---|---|
| Drug Class | NSAID (Anti-inflammatory) | Antihistamine (Anti-allergy) |
| Primary Target | **Post-Surgical Pain** | Allergic Itching/Redness |
| Mechanism | Prostaglandin Inhibition | Histamine H1 Antagonism |
| Best For | Cataract Recovery | Seasonal Allergy |
6. Dosing & Administration
Perioperative Surgical Regimen
- Pre-Surgery: Instill 1 drop three times daily, starting 1 day before surgery.
- Day of Surgery: 1 drop on the morning of the procedure.
- Post-Surgery: 1 drop three times daily for up to 2 weeks, or as directed by your surgeon.
Application Guidelines
- Wash hands and shake the bottle well (suspension must be mixed).
- Tilt the head back and pull down the lower lid.
- Instill one drop without touching the dropper tip to the eye.
- 目を閉じ、内側の隅に60秒間軽く圧を加えてください。
- 他の点眼薬を使用する場合は、少なくとも5分間の間隔を空けてください。
7. 注意事項と安全上の警告
- 出血傾向: 既知の出血傾向がある患者や血液凝固阻害薬を使用中の患者は慎重に使用してください。
- 角膜への影響: 非ステロイド性消炎剤の長期使用は、角膜炎や角膜の薄化を引き起こす可能性があります。長期使用の場合は専門医によるモニタリングが必要です。
- コンタクトレンズ: 手術後期間中はXinepを使用中はコンタクトレンズの装着を避けてください。
8. 徹底的に調査されたFAQ
Q: Xinepはステロイド点眼薬ですか？
A: いいえ。Xinepは非ステロイド性抗炎症薬（NSAID）です。ステロイドに伴う眼圧上昇などの副作用を伴わず、強力な抗炎症作用を提供します。
Q: なぜボトルを振る必要があるのですか？
A: Xinepは懸濁液であるため、薬剤が底部に沈殿します。振ることで、毎回正確な投与量を得られるようにします。
Q: アレルギーによる赤みにXinepを使用できますか？
A: Xinepは炎症を抑える効果がありますが、抗ヒスタミン剤ではありません。アレルギー性の赤みには、通常オロパタジンなどの製品の方が効果的です。
9. 公式規制参照
- Sunways Ophthalmic Index: 公式製品一覧
- FDA Monographs: Nepafenac 0.1%の臨床薬理学。
医療上の免責事項: 本コンテンツは教育目的でAIが生成したものであり、医療アドバイスではありません。診断や治療については必ず医師や医療専門家にご相談ください。
レビュー
レビューはまだありません。